BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17062600)

  • 21. Biokinetic models for the behaviour of carbon-14 from labelled compounds in the human body: can a single generic model be justified?
    Taylor DM
    Radiat Prot Dosimetry; 2004; 108(3):187-202. PubMed ID: 15031441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A generic biokinetic model for Carbon-14.
    Manger RP
    Radiat Prot Dosimetry; 2011 Jan; 143(1):42-51. PubMed ID: 21075764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in internal dosimetry models.
    Nosske D; Blanchardon E; Bolch WE; Breustedt B; Eckerman KF; Giussani A; Harrison JD; Klein W; Leggett RW; Lopez MA; Luciani A; Zankl M
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):314-20. PubMed ID: 21036807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICRP Publication 134: Occupational Intakes of Radionuclides: Part 2.
    Paquet F; Bailey MR; Leggett RW; Lipsztein J; Fell TP; Smith T; Nosske D; Eckerman KF; Berkovski V; Ansoborlo E; Giussani A; Bolch WE; Harrison JD;
    Ann ICRP; 2016 Dec; 45(3-4):7-349. PubMed ID: 28657340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective quality factors for neutrons based on the revised ICRP/ICRU recommendations.
    Veinot KG; Hertel NE
    Radiat Prot Dosimetry; 2005; 115(1-4):536-41. PubMed ID: 16381781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the reliability of dose coefficients for exposure to radioiodine by members of the public, accounting for dosimetric and risk model uncertainties.
    Puncher M; Zhang W; Harrison JD; Wakeford R
    J Radiol Prot; 2017 Jun; 37(2):506-526. PubMed ID: 28586312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation doses to members of the U.S. population from ubiquitous radionuclides in the body: Part 2, methods and dose calculations.
    Watson DJ; Strom DJ
    Health Phys; 2011 Apr; 100(4):377-401. PubMed ID: 21350345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uncertainty analysis of doses from ingestion of plutonium and americium.
    Puncher M; Harrison JD
    Radiat Prot Dosimetry; 2012 Feb; 148(3):284-96. PubMed ID: 21498415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of a new biokinetic model of zirconium in internal dosimetry: part II, parameter sensitivity analysis.
    Li WB; Greiter M; Oeh U; Hoeschen C
    Health Phys; 2011 Dec; 101(6):677-92. PubMed ID: 22048486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of uncertainty in transfer rates for the ICPR publication 67 biokinetic model on dose estimation for 239Pu from results of individual monitoring. International Commission on Radiological Protection.
    Suzuki K; Sekimoto H; Ishigure N
    Radiat Prot Dosimetry; 2002; 102(4):333-41. PubMed ID: 12474943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing dose of the representative person for the purpose of radiation protection of the public. ICRP publication 101. Approved by the Commission in September 2005.
    ICRP
    Ann ICRP; 2006; 36(3):vii-viii, 5-62. PubMed ID: 17174713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doses to the embryo and fetus from intakes of radionuclides by the mother. A report of The International Commission on Radiological Protection.
    Ann ICRP; 2001; 31(1-3):19-515. PubMed ID: 11730884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
    Li WB; Oeh U; Paretzke HG
    Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A commentary on some inconsistencies in the icrp 2005 recommendations: exclusion levels.
    Kramer GH
    Health Phys; 2006 Jul; 91(1):1-6. PubMed ID: 16775474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICRP Publication 137: Occupational Intakes of Radionuclides: Part 3.
    Paquet F; Bailey MR; Leggett RW; Lipsztein J; Marsh J; Fell TP; Smith T; Nosske D; Eckerman KF; Berkovski V; Blanchardon E; Gregoratto D; Harrison JD;
    Ann ICRP; 2017 Dec; 46(3-4):1-486. PubMed ID: 29380630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The computation of ICRP dose coefficients for intakes of radionuclides with PLEIADES: biokinetic aspects.
    Fell TP
    Radiat Prot Dosimetry; 2007; 127(1-4):220-2. PubMed ID: 17921508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICRP Publication 119: Compendium of dose coefficients based on ICRP Publication 60.
    ; Eckerman K; Harrison J; Menzel HG; Clement CH
    Ann ICRP; 2012; 41 Suppl 1():1-130. PubMed ID: 23025851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A framework for assessing the impact of ionising radiation on non-human species. ICRP Publication 91.
    Valentin J;
    Ann ICRP; 2003; 33(3):207-66. PubMed ID: 12963089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The internal dosimetry code PLEIADES.
    Fell TP; Phipps AW; Smith TJ
    Radiat Prot Dosimetry; 2007; 124(4):327-38. PubMed ID: 17766256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basis and implications of the ICRP's new biokinetic model for thorium. International Commission on Radiological Protection.
    Leggett RW
    Health Phys; 1997 Oct; 73(4):587-600. PubMed ID: 9314218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.